Efg Capital International Corp. »

Alnylam Pharmaceuticals shares owned by Efg Capital International Corp.

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Efg Capital International Corp. from 13F filings

Historical chart of Efg Capital International Corp. investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Efg Capital International Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Efg Capital International Corp.

Quarter filed Position value Share count Share price at filing
2023-06-30 $3.0M 16k 189.94

More positions owned by Efg Capital International Corp.

Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Verisk Analytics (VRSK)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Pepsi (PEP)
Cme (CME)
Adobe Systems Incorporated (ADBE)
Tesla Motors (TSLA)
Netflix (NFLX)
JPMorgan Chase & Co. (JPM)

View all positions for Efg Capital International Corp.

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
FMR
BlackRock
Wellington Management Company
Baillie Gifford & Co
T. Rowe Price Associates
Dodge & Cox
T. Rowe Price Investment Management
Geode Capital Management
Jpmorgan Chase & Co
American Century Companies
Susquehanna International
venBio Select Advisor
Pictet Asset Management Holding SA
Legal & General Group

View all funds holding Alnylam Pharmaceuticals